Cipher PharmaceuticalsCipher is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products ProductsPipeline NewsCipher Pharmaceuticals Announces A-101 40% Topical Solution Accepted for Review by Health Canada December 18, 2018Cipher Pharmaceuticals Announces PLECANATIDE Accepted for Review by Health Canada December 17, 2018Events Tuesday, December 11, 2018 11:00 am ET Investor Presentation Webcast Webcast Investors Financial Reports Investor Presentation Corporate Governance Documents Webcasts
